TW200307676A - Manufacture of ketopantolactone - Google Patents

Manufacture of ketopantolactone Download PDF

Info

Publication number
TW200307676A
TW200307676A TW092108813A TW92108813A TW200307676A TW 200307676 A TW200307676 A TW 200307676A TW 092108813 A TW092108813 A TW 092108813A TW 92108813 A TW92108813 A TW 92108813A TW 200307676 A TW200307676 A TW 200307676A
Authority
TW
Taiwan
Prior art keywords
ruthenium
pantolactone
solvent system
periodate
patent application
Prior art date
Application number
TW092108813A
Other languages
Chinese (zh)
Inventor
Werner Bonrath
Reinhard Karge
Matthias Nuechter
Bernd Ondruschka
Original Assignee
Roche Vitamins Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Vitamins Ag filed Critical Roche Vitamins Ag
Publication of TW200307676A publication Critical patent/TW200307676A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Catalysts (AREA)

Abstract

A process for the oxidation of pantolactone to ketopantolactone comprises carrying out the oxidation with a periodate in the presence of a ruthenium catalyst, in an aqueous solvent system and in a microwave field. Ketopantolactone is a key intermediate in the manufacture of pantothenic acid, the latter being a member of the B complex vitamins and a constituent of coenzyme A. Asymmetric hydrogenation of ketopantolactone yields (D)- (-)-pantolactone, from which pantothenic acid can then be manufactured.

Description

200307676 玫、發明說明: 【發明所屬之技術領域】 本發明涉及一種製造酮基泛解酸内酯的氧化反應方法, 特別涉及一種在微波場中將泛解酸内酯氧化為酮基泛解酸 内酯之方法。 【先前技術】 酮基泛解酸内酯係製造泛解酸的關鍵中間物,而泛解酸 係複合維他命B的成貝之一且為輔酶的構成成分。酮基泛解 酸内酯之非對稱氫化作用生成了(D)_(-)-泛解酸内酯,隨後 即由此化合物製得泛解酸。 由泛解酸内酯(其係具有下列分子式之化合物)200307676 Rose and description of the invention: [Technical field to which the invention belongs] The present invention relates to an oxidation reaction method for producing ketopantolactone, in particular to an oxidation reaction of pantolactone to ketopantoate in a microwave field Method of lactone. [Previous Technology] Keto-pantolactone is a key intermediate in the production of pantothenic acid, while pantothenic acid is one of the shellfish of vitamin B complex and is a constituent of coenzyme. The asymmetric hydrogenation of keto-pantoic acid lactones yields (D) _ (-)-pantoic acid lactones. Pantoic acids are then prepared from this compound. By pantolactone (which is a compound having the following formula)

氧化成下列分子式之酮基泛解酸内酯之反應Reaction of oxidation to ketopantolactone of the following formula

已在各種公開案中有所描述,例如:日本未審查專利公開 案 Kokai 04/095087 A2 (CA117 ’ 69720m):使用二氧化錳之 氧化反應;日本未審查專利公開案Kokai 04/095086 A2 rCA117 ’ 69719t)及日本未審查專利公開案Kokai 05/306276 A2 rCA120 ’ 163965d):使用二甲基亞颯之氧化反應;日本 未審查專利公開案Kokai 61/242586 A2〔CA107,5783v)及 200307676It has been described in various publications, for example: Japanese Unexamined Patent Publication Kokai 04/095087 A2 (CA117 '69720m): Oxidation reaction using manganese dioxide; Japanese Unexamined Patent Publication Kokai 04/095086 A2 rCA117' 69719t) and Japanese Unexamined Patent Publication Kokai 05/306276 A2 rCA120'163163d): Oxidation reaction using dimethyl sulfene; Japanese Unexamined Patent Publication Kokai 61/242586 A2 [CA107,5783v) and 200307676

Reel. Trav· Chim· Pays-Bas,110(5),155_7(1991):微生物 氧化反應;Synth· Commun· 14(7),第 697-700 頁(1984):釕 催化之需氧氧化反應;及「應用化學」(Angew. Chem.) 96(7) ’第519-520頁(1984):使用第三丁基過氧化氫以釘催化脫 氫反應。 迄今為止,現有之方法對於將酮基泛解酸内酯用於商用 規模生產之產率、選擇性及反應時間方面尚不盡如人意。 【發明内容】 頃發現在水性溶劑系統及微波場中,於釕系催化劑存在 下,藉由泛解酸内酯與過碘酸鹽(1〇4·,亦稱為"偏過碘酸 鹽;下文所提及之"過碘酸鹽")之氧化反應,可在較短之反 應時間内製得具有良好選擇性、轉換性之酮基泛解酸内 酯。因而,本發明提供一種用於將泛解酸内酯之方法,該 方法包括在水性溶劑系統及微波場中,於釕系催化劑存在 下,與過碘酸鹽進行氧化反應。 本發明所述之方法中所使用之過琪酸鹽宜為鹼金屬過酸 鹽,譬如:過碘酸鈉或過碘酸鉀[Na+I04·或ΚΊΟ^]。釕系催 化劑可為氧化方法中常用且應易溶解於本發明方法所使用 之水性溶劑系統中之任何釕系催化劑。該等催化劑之實例 為釕(皿)鹽,譬如釕(瓜)鹵化物,特定言之為氣化釕 (瓜)[RuCl3]及溴化釕(皿)[RuBr3];及釕氧化物,特定言之為 三氧化二釕(瓜)[Ru2〇3]及其水合物、氧化釕(IV)[Ru〇2]及其 水合物。較佳之催化劑為氯化釕(瓜)。 本文中所使用之術語,,水性溶劑系統"意指包括由水及可 84740 200307676 溶於水之有機溶劑組成之混合物之溶劑系統,且泛解酸内 酯及酮基泛解酸内酯應可溶於其中。該有機溶劑必須至少 部分可溶於水;依所使用之有機溶劑而定,該系統通常為 雙相系統。例如以乙酸乙酯作為該有機溶劑即屬此狀況。 該等適合之有機溶劑之實例為脂系酯,例如乙酸乙酯及乙 酸異丙酯;環狀酯,例如r-丁内酯;及碳酸酯,例如碳酸 乙烯酯及碳酸丙婦酯。較佳為雙相水性溶劑系統。該水性 溶劑系統中水與該有機溶劑之體積比以約丨5:1至約1〇:1為 適且,以約3:1至約5:1為較佳。溶劑系統中水之用量相對於 初始物質泛解酸内酯之用量以每毫莫耳泛解酸内酯使用約 1毫升至約5毫升水為適宜,以每毫莫耳泛解酸内酯使用約 1·5笔升至約2.5毫升水為較佳。較佳之有機溶劑係乙酸乙 酯,含乙酸乙酯作為有機溶劑之較佳水性溶劑系統係由約2 個體積之水對1個體積之乙酸乙酯之比例組成之混合物。 不論其特性如何,本發明之方法中,過碘酸鹽之用量相 對於初始物質泛解酸内酯之用量以每1克泛解酸内酯使用 約4克至約10克過琪酸鹽為適宜,以每j克泛解酸内酯使用 約4·5克至約6.5克過碘酸鹽為較佳。 在釕系催化劑之相對用量方面,適宜用量係每丨克泛解酸 内酯使用約0·001克至約〇.〇5克釕系催化劑,較佳為每i克泛 解酸内酯使用約0.01克至約〇·〇15克該催化劑。 該微波場可藉由任一習知使用之微波發射設備提供。本 文所用之術語’’微波"指頻率為3〇〇 MHz至30 GHz之電磁波 譜區域’因此相應波長為1 m至1 cm。為了不干擾雷達之波 84740 -8 - 200307676 長(1 cm至25 cm),依據國際規範,工業用微波發射器之操 作波長應為 12.2 cm (2.45 GHz)或 33 ·3 cm (900 MHz)。此方 面可參閱「化學學會综述」(Chem· Soc. Rev·)逆,第1-47 頁(1991年)。因此,在本發明之較佳具體實施例中,施加之 微波場具有約12.2 cm或約33.3 cm之波長。通常,該微波場 係用於促進為時約1分鐘至約60分鐘(以約5分鐘至約40分 鐘較佳,約10分鐘至約30分鐘尤佳)之氧化作用。 本發明之方法中適宜使用之微波反應器為諸如該等處於 ’•Ethos”範圍之内之反應器,如MLS GmbH公司(Auenweg 37, D-88299 Leutkirch im Allgau,德國)所提供之Ethos 1600 反應器(德國以外之供應商為如Milestone S.r.l·,Via Fatebenefratelli,1/5,I_24010 Sorisole (BG),義大利及 Milestone Inc.,160 B Shelton Road,Monroe,CT 06468, 美國)。本發明之方法中的輻照宜採用約400瓦特至約1000 瓦特之照射率進行,以約500瓦特至約800瓦特為更佳。 依據本發明所述之氧化方法,所施加之微波場最好使得 該氧化作用可在所使用之水性溶劑系統之沸點溫度下進 行。 在本發明方法之較佳具體實施例中,該微波場係施加至 含在適當水性溶劑系統中的泛解酸内酯及釕系催化劑之溶 液,直至該反應混合物之溫度達到其沸點,亦即回流溫度 為止,此時可添加過碘酸鹽氧化劑。該反應適宜藉由如氣 相層析法監控,以確定由泛解酸内酯形成所期望之酮基泛 解酸内酯之最佳轉化點。藉此方法可避免若因反應時間不 84740 -9- 200307676 必要地延長而可能形成非預期之產物及因此有可能降低最 終獲得之酮基泛解酸内酯之產率之問題。一旦達到解酸内 酯形成酮基泛解酸内酯之最隹轉化點時,典型的在初始之 泛解酸内酯完成80%之轉化後’即冷卻反應溶液,並適當 地藉由過滤去除固態物質之後’分離兩個溶劑相及蒸發非 水相,單離出期望之產物-酮基泛解酸内酯。該水相通常包 含未反應之物質,若須要,可再循環,特別回收其中未反 應之泛解酸内酯。 【實施方式】 以下實例對本發明進行了闡述。 實例 取由29.5克之泛解酸内酯、300毫克之氣化釕(in)、400 毫升水及200毫升之乙酸乙酯組成之混合物,藉由具有700 瓦特之輸出功率之微波反應器(Ethos 1600,可自德國MLS GmbH公司,D-88299 Leutkirch im Allgau獲得)產生之微波 場攪拌加熱至回流溫度。在十分鐘内,添加145.5克之(偏) 過碘酸鈉至該沸騰之混合物中。接著再攪拌該反應混合物 20分鐘,然後快速冷卻。自該水相中分離有機相,抽吸過 濾有機相中之碘酸鈉沉澱,以20毫升之乙酸乙酯沖洗5次。 分離雙相混合物,且該水相以50毫升之乙酸乙酯萃取2次。 合併之有機相以無水硫酸鎂脫水,過濾及減壓蒸發。所得 之酮基泛解内酿之純度為98%,按初始泛解酸内酿計,產 率為60%。可再自該水相中單離出12%產物。未反應之泛解 酸内酯可自該水相中收回。 84740 • 10 · 200307676 遵循此製程,80%之初始泛解酸内酯可轉化為酮基泛解 酸内酯,並可達到0.95之選擇性。 84740 •11-Reel. Trav · Chim · Pays-Bas, 110 (5), 155_7 (1991): Microbial oxidation reaction; Synth · Commun · 14 (7), pp. 697-700 (1984): Aerobic oxidation reaction catalyzed by ruthenium; And "Angew. Chem." 96 (7) pp. 519-520 (1984): the use of a third butyl hydrogen peroxide to catalyze the dehydrogenation reaction. To date, existing methods have been unsatisfactory in terms of yield, selectivity, and reaction time for the use of ketopantolactones for commercial scale production. [Summary of the invention] It is found that in an aqueous solvent system and a microwave field, in the presence of a ruthenium-based catalyst, pantolactone and periodate (104 ··, also known as " metaperiodate) The oxidation reaction of " periodate " mentioned below can produce ketopantolactone with good selectivity and conversion in a short reaction time. Accordingly, the present invention provides a method for pantolactone, which method comprises performing an oxidation reaction with periodate in the presence of a ruthenium-based catalyst in an aqueous solvent system and a microwave field. The perchlorate used in the method of the present invention is preferably an alkali metal peracid, such as sodium periodate or potassium periodate [Na + I04 · or ΚΊΟ ^]. The ruthenium-based catalyst may be any ruthenium-based catalyst which is commonly used in oxidation methods and should be easily soluble in the aqueous solvent system used in the method of the present invention. Examples of such catalysts are ruthenium (dish) salts, such as ruthenium (melon) halides, specifically gaseous ruthenium (melon) [RuCl3] and ruthenium bromide (dish) [RuBr3]; and ruthenium oxides, specifically These are ruthenium trioxide (melon) [Ru203] and its hydrate, and ruthenium (IV) oxide [Ru〇2] and its hydrate. The preferred catalyst is ruthenium chloride (melon). As used herein, the term "aqueous solvent system" means a solvent system including a mixture of water and an organic solvent that is soluble in water from 84740 200307676. The pantolactone and ketopantolactone should be Soluble in it. The organic solvent must be at least partially soluble in water; depending on the organic solvent used, the system is usually a two-phase system. This is the case, for example, with ethyl acetate as the organic solvent. Examples of such suitable organic solvents are aliphatic esters such as ethyl acetate and isopropyl acetate; cyclic esters such as r-butyrolactone; and carbonates such as ethylene carbonate and propyl carbonate. A two-phase aqueous solvent system is preferred. The volume ratio of water to the organic solvent in the aqueous solvent system is suitably about 5: 1 to about 10: 1, and more preferably about 3: 1 to about 5: 1. The amount of water in the solvent system is relative to the amount of pantolactone in the starting material. It is suitable to use about 1 ml to about 5 ml of water per millimolar pantolactone, and to use per millimolar pantolide About 1.5 pens to about 2.5 milliliters of water is more preferred. The preferred organic solvent is ethyl acetate, and the preferred aqueous solvent system containing ethyl acetate as the organic solvent is a mixture consisting of a ratio of about 2 volumes of water to 1 volume of ethyl acetate. Regardless of its characteristics, in the method of the present invention, the amount of periodate relative to the amount of the starting material pantolactone is about 4 to about 10 grams of perkidate per gram of pantolactone. Conveniently, from about 4.5 grams to about 6.5 grams of periodate per j grams of pantolactone is preferred. In terms of the relative amount of ruthenium-based catalyst, a suitable amount is about 0.001 to about 0.05 g of ruthenium-based catalyst per gram of pantolactone, preferably about 1 to 1 gram of pantolactone. 0.01 g to about 0.015 g of the catalyst. The microwave field can be provided by any conventionally used microwave transmitting device. The term '' microwave 'as used herein refers to the electromagnetic spectrum region having a frequency of 300 MHz to 30 GHz and therefore a corresponding wavelength of 1 m to 1 cm. In order not to interfere with radar waves 84740 -8-200307676 long (1 cm to 25 cm), according to international regulations, the operating wavelength of industrial microwave transmitters should be 12.2 cm (2.45 GHz) or 33.3 cm (900 MHz). In this regard, see "Review of the Chemical Society" (Chem. Soc. Rev.), page 1-47 (1991). Therefore, in a preferred embodiment of the present invention, the applied microwave field has a wavelength of about 12.2 cm or about 33.3 cm. Generally, the microwave field is used to promote oxidation for about 1 minute to about 60 minutes (preferably about 5 minutes to about 40 minutes, and particularly preferably about 10 minutes to about 30 minutes). Suitable microwave reactors for use in the method of the present invention are such reactors within the scope of '• Ethos', such as the Ethos 1600 reaction provided by MLS GmbH (Auenweg 37, D-88299 Leutkirch im Allgau, Germany). (Suppliers outside Germany such as Milestone Srl ·, Via Fatebenefratelli, 1/5, I_24010 Sorisole (BG), Italy and Milestone Inc., 160 B Shelton Road, Monroe, CT 06468, USA). Method of the invention The irradiation in the medium should preferably be performed with an irradiation rate of about 400 watts to about 1,000 watts, and more preferably about 500 watts to about 800 watts. According to the oxidation method of the present invention, the applied microwave field preferably makes the oxidation effect It can be carried out at the boiling temperature of the aqueous solvent system used. In a preferred embodiment of the method of the present invention, the microwave field is applied to a pantolactone and a ruthenium-based catalyst contained in a suitable aqueous solvent system. Solution until the temperature of the reaction mixture reaches its boiling point, that is, the reflux temperature, at which time periodate oxidant can be added. The reaction is suitably carried out by, for example, a gas phase layer Monitoring to determine the optimal conversion point for the formation of the desired ketopantolactone from pantolactone. This method can avoid the possibility of non-prone formation if the reaction time is unnecessarily extended 84740 -9- 200307676 The expected product and therefore the possibility of lowering the yield of the ketopantolactone finally obtained. Once the maximum conversion point to form the ketopantolactone is reached, typically at the initial After 80% conversion of pantolactone is completed, the reaction solution is cooled, and the solid phase is appropriately removed by filtration. The two solvent phases are separated and the non-aqueous phase is evaporated to separate the desired product, keto-pantolysis. Acid lactones. The water phase usually contains unreacted materials. If necessary, they can be recycled, and the unreacted pantoic acid lactones can be recovered in particular. [Embodiments] The following examples illustrate the invention. The examples are based on 29.5 grams A mixture of pantolactone, 300 mg of ruthenium (in) vaporized, 400 ml of water and 200 ml of ethyl acetate, using a microwave reactor (Ethos 1600, 700 Mw, available from MLS, Germany) GmbH, obtained from D-88299 Leutkirch im Allgau) and heated to reflux temperature with stirring. Within ten minutes, 145.5 grams of (meta) sodium periodate was added to the boiling mixture. The reaction mixture was then stirred again 20 Minutes, then rapid cooling. The organic phase was separated from the aqueous phase, the sodium iodate precipitate in the organic phase was filtered with suction, and washed 5 times with 20 ml of ethyl acetate. The biphasic mixture was separated, and the aqueous phase was separated with 50 ml It was extracted twice with ethyl acetate. The combined organic phases were dehydrated with anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The purity of the obtained keto-based hydrolyzed internal fermentation was 98%, and the yield was 60% based on the initial pan-hydrolyzed internal fermentation. A further 12% of the product can be isolated from this aqueous phase. Unreacted pantolides can be recovered from the aqueous phase. 84740 • 10 · 200307676 Following this process, 80% of the initial pantolactone can be converted to ketopantolactone with a selectivity of 0.95. 8474011-

Claims (1)

200307676 拾、申請專利範固: 1· 一種將泛解酸内酯氧化為酮基泛解酸内酯之方法,其包 括在水性溶劑系統及微波場中,於釕系催化劑存在下, 與過碘酸鹽進行氧化反應。 根據申請專利範圍第!項之方法,其中該過琪酸鹽係驗金 碘金屬過碘酸鹽,以過碘鈉或過碘鉀為較^圭。 3·根據申請專利範圍第1或2項之方法,其中該釕系催化劑 為可溶於所使用之水溶劑系統之釕(ΠΙ)鹽,以釕(ΙΠ)鹵化 或釘乳化物或其水合物為較佳。 4.根據申請專利範圍第3項之方法,其中該釕(Ιπ)鹽係氣化 釕(III)、溴化釕(ΠΙ)、三氧化二釕(ΠΙ)或其水合物、或氧 化釕(IV)或其水合物。 5·根據申請專利範圍第1至4項中任一項之方法,其中該水 性溶劑系統之有機溶劑為脂系酯,以乙酸乙酯或乙酸異 丙酯為較佳;環狀酯,較佳為^ -丁内酯;或碳酸酯,較 佳為碳酸乙缔酯或碳酸丙烯酯。 6.根據申請專利範圍第1至5項中任一項之方法,其中該水 性溶劑系統中水與該有機溶劑之體積比為約1 5 : 1至約 10:1,以約3 : 1至約5:1為較佳。 7·根據申請專利範圍第1至6項中任一項之方法,其中該水 性溶劑系統為包括乙酸乙酯作為有機溶劑之雙相溶劑系 統。 8‘根據申請專利範圍第1至7項中任一項之方法,其中過硪 酸鹽之用量相對於初始物質泛解酸内酿之用量為每1克 84740 200307676 泛解酸内酯使用約4克至約10克過碘酸鹽,以每1克泛解 酸内酯使用约4·5克至約6.5克過碘酸鹽為較佳。 9·根據申請專利範圍第1至8項中任一項之方法,其中每1克 泛解酸内酯使用約0.001克至約0.05克釕系催化劑,較佳 為每1克泛解酸内酯使用約0.01克至約0.015克該催化劑。 10.根據申請專利範圍第1至9項中任一項之方法,其中該微 波場之波長為約12 · 2公分或約3 3.3公分。 11·根據申請專利範圍第1至10項中任一項之方法,其中所施 加之微波場使得該氧化作用可在所使用之水性溶劑系統 之沸點溫度下進行。 200307676 柒、指定代表圖: (一) 本案指定代表圖為:第()圖。 (二) 本代表圖之元件代表符號簡單說明: 捌、本案若有化學式時,請揭示最能顯示發明特徵的化學式:200307676 Application and patent application: 1. A method for oxidizing pantolactone to ketopantolactone, which includes an aqueous solvent system and a microwave field in the presence of a ruthenium-based catalyst and periodine. The acid salt undergoes an oxidation reaction. According to the scope of patent application! The method of item, wherein the periodate is a gold iodide periodate, and sodium periodate or potassium periodate is preferred. 3. The method according to item 1 or 2 of the scope of patent application, wherein the ruthenium-based catalyst is a ruthenium (II) salt soluble in the used water solvent system, and is halogenated or nail-emulsified with ruthenium (ΙΠ) or its hydrate Is better. 4. The method according to item 3 of the scope of patent application, wherein the ruthenium (Ιπ) salt is vaporized ruthenium (III), ruthenium bromide (ΠΙ), ruthenium trioxide (ΠΙ) or a hydrate thereof, or ruthenium oxide ( IV) or a hydrate thereof. 5. The method according to any one of claims 1 to 4, wherein the organic solvent of the aqueous solvent system is a fatty ester, preferably ethyl acetate or isopropyl acetate; a cyclic ester, preferably ^ -Butyrolactone; or carbonate, preferably ethylene carbonate or propylene carbonate. 6. The method according to any one of claims 1 to 5, wherein the volume ratio of water to the organic solvent in the aqueous solvent system is about 15: 1 to about 10: 1, and about 3: 1 to About 5: 1 is better. 7. The method according to any one of claims 1 to 6, wherein the aqueous solvent system is a two-phase solvent system including ethyl acetate as an organic solvent. 8 'The method according to any one of items 1 to 7 of the scope of the patent application, wherein the amount of peracetate relative to the amount of the starting substance pantolactone is about 4 per 1 gram 84740 200307676 pantolide G to about 10 g of periodate, preferably about 4.5 g to about 6.5 g of periodate per 1 g of pantolactone. 9. The method according to any one of claims 1 to 8, wherein about 0.001 to about 0.05 g of a ruthenium-based catalyst is used per 1 g of pantolactone, preferably 1 g of pantolactone About 0.01 g to about 0.015 g of the catalyst is used. 10. The method according to any one of claims 1 to 9, wherein the wavelength of the microwave field is about 12.2 cm or about 3 3.3 cm. 11. A method according to any one of claims 1 to 10 in the scope of the patent application, wherein the applied microwave field allows the oxidation to be performed at the boiling temperature of the aqueous solvent system used. 200307676 (1) Designated representative map: (1) The designated representative map in this case is: (). (2) A brief description of the representative symbols of the components in this representative drawing: 捌 If there is a chemical formula in this case, please disclose the chemical formula that can best show the characteristics of the invention: 〇 〇 84740〇 〇 84740
TW092108813A 2002-04-25 2003-04-16 Manufacture of ketopantolactone TW200307676A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02009428 2002-04-25

Publications (1)

Publication Number Publication Date
TW200307676A true TW200307676A (en) 2003-12-16

Family

ID=29265899

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092108813A TW200307676A (en) 2002-04-25 2003-04-16 Manufacture of ketopantolactone

Country Status (5)

Country Link
KR (1) KR100969111B1 (en)
CN (1) CN1332956C (en)
AU (1) AU2003240450A1 (en)
TW (1) TW200307676A (en)
WO (1) WO2003091235A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113816932B (en) * 2021-10-14 2023-03-17 宁夏优维生物科技有限公司 Synthesis of keto pantolactone
CN115536520A (en) * 2022-11-02 2022-12-30 金川集团股份有限公司 Preparation method of ruthenium acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225506A (en) * 1978-05-30 1980-09-30 Hoffmann-La Roche Inc. Process for manufacturing a diketone
DE3229026A1 (en) * 1982-08-04 1984-02-09 Basf Ag, 6700 Ludwigshafen METHOD FOR PRODUCING 4,4-DIMETHYL-TETRAHYDROFURAN-2,3-DION
DE3242560A1 (en) * 1982-11-18 1984-05-24 Basf Ag, 6700 Ludwigshafen METHOD FOR PRODUCING DIHYDRO-4,4-DIMETHYL-2,3-FURANDION
JPS61242586A (en) 1985-04-19 1986-10-28 Seitetsu Kagaku Co Ltd Production of ketopantoic acid salt and/or ketopantolactone
JPH05306276A (en) * 1992-04-27 1993-11-19 Mitsubishi Petrochem Co Ltd Production of ketopantolactone

Also Published As

Publication number Publication date
KR100969111B1 (en) 2010-07-09
CN1332956C (en) 2007-08-22
AU2003240450A1 (en) 2003-11-10
CN1649860A (en) 2005-08-03
KR20040111543A (en) 2004-12-31
WO2003091235A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
CN109456157A (en) A method of L- menthones is prepared by R- citronellal
JP3715492B2 (en) Improved process for the production of benzaldehyde by catalytic liquid phase air oxidation of toluene
TW200307676A (en) Manufacture of ketopantolactone
CN105017099B (en) Sitagliptin chiral intermediate and asymmetric synthesis method thereof
JP6245605B2 (en) Process for producing .ALPHA.,. BETA.-unsaturated carbonyl compounds.
JPS5865241A (en) Carbonylation of secondary benzylhalide
WO2009110217A1 (en) Hydroxyapatite with silver supported on the surface thereof
JP2008019265A (en) METHOD FOR PRODUCING beta-HYDROXYHYDROPEROXIDE AND CATALYST FOR THE SAME
CN114163323A (en) Synthetic method of 3-oxocyclobutanecarboxylic acid
JPH08311025A (en) Production of 4-hydroxy-2-pyrrolidone
JPS6017776B2 (en) Production method of γ-chloro-β-hydroxybutyric acid alkyl ester
JP4066679B2 (en) Process for producing aralkyl ketones and catalyst thereof
Shi et al. Preparation, characterization and catalytic oxidation properties of bis‐quaternary ammonium peroxotungstates and peroxomolybdates complexes
CN109796416A (en) A kind of synthetic method of 2- acetyl group pyrazine
CN113943220B (en) Photochemical synthesis method of 1, 4-dicarbonyl compound derivative
CN103819489A (en) Preparation method of penicillanic acid sulphoxide diphenyl methyl ester
CN108516938B (en) Method for preparing osteoarthritis treatment drug intermediate 6-carbonyl methyl hexanoate
JPH021819B2 (en)
JP4759177B2 (en) Method for producing mevalolactone
JPH1180096A (en) Production of dimethyl carbonate
JPH0892150A (en) Production of 5(e), 8(z), 11(z)-tetradecatrien-2-one
JPS63214353A (en) Catalyst for reducing carboxylic acid or ester thereof to aldehyde compound
JPS62298546A (en) Production of anisaldehyde
JP2001206883A (en) Method for producing 3,4-methylenedioxymandelic acid
KR101642960B1 (en) Preparation method of benzoic acid